Spectrum pharmaceuticals analyst coverage. One research analyst has rated the stock ...

Spectrum pharmaceuticals analyst coverage. One research analyst has rated the stock with a sell recommendation, five have issu The Financial Services equity research team maintains coverage of approximately 270 companies spanning the four key sectors of banking, capital markets, insurance, and specialty finance. 5 days ago · In-depth global journalism and expert analysis of the pharma, biotech, medtech, and consumer health industries. We go beyond the headlines to deliver news with context and impact. or its management. May 14, 2023 · Story continues Better yet, Spectrum Pharmaceuticals is expected to break-even soon - within the next few years - according to analyst forecasts, which would be a momentous event for shareholders. The Investor Relations website contains information about ARS Pharmaceuticals's business for stockholders, potential investors, and financial analysts. The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts. Spectrum Brands, Inc. . (NASDAQ:ACAD - Get Free Report) have received an average recommendation of "Moderate Buy" from the twenty analysts that are currently covering the firm, MarketBeat. The company has an average price target of $7. View today's Spectrum Pharmaceuticals Inc stock price and latest SPPI news and analysis. Seeking Alpha is the leading financial website for crowdsourced opinion and analysis of stocks, bonds and other investment analysis. Please note that any opinions, estimates or forecasts regarding Spectrum Brands, Inc. 0 with a high of $12. Find the latest Spectrum Pharmaceuticals Inc (SPPI) stock forecast, 12-month price target, predictions and analyst recommendations. 's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Spectrum Brands, Inc. Where is Spectrum Pharmaceuticals stock heading? Wall Street analysts weigh in with their latest ratings and SPPI price targets at PriceTargets. Equip yourself with the right knowledge to make informed investing decisions. Check stock performance, fundamentals, market cap, shareholding Get free stock quotes, financial news, portfolio tools, market data, and mortgage rates to manage your finances on Yahoo Finance. Can you provide the consensus rating for SPECTRUM PHARMACEUTICALS INC stock? The consensus rating for SPECTRUM PHARMACEUTICALS INC (SPPI) is 50 / 100 . In the last 3 months, 4 analysts have offered 12-month price targets for Spectrum Pharmaceuticals. com. The Investor Relations website contains information about Xenon Pharmaceuticals Inc. com reports. This indicates that analysts generally have a neutral outlook on the stock. Get comprehensive coverage of stocks, investment strategies, financial forecasts, and more from top industry professionals. Spectrum Pharmaceuticals Inc (SPPI) Spectrum Pharmaceuticals Inc stock price live, this page displays NASDAQ SPPI stock exchange data. is followed by the analysts listed. Below is a summary of how these 4 analysts rated Spectrum Pharmaceuticals over the past 3 months. SPPI Ratings News B. Monitor the latest movements within the Spectrum Pharmaceuticals Inc real time stock price chart below. Riley/FBR Starts Spectrum Pharmaceuticals (SPPI) at Buy Guggenheim Resumes Spectrum Pharmaceuticals (SPPI) at Buy Jefferies Resumes Spectrum Pharmaceuticals Stay updated with the latest stock market news, trends, and insights on GuruFocus Stock News Page. View the SPPI premarket stock price ahead of the market session or assess the after hours quote. Create real-time notifications to follow any changes in the live stock price. 00. 14 hours ago · Shares of ACADIA Pharmaceuticals Inc. 00 and a low of $1. 1 day ago · Syngene International Share Price Today 2 Mar 2026: Track Syngene International share price today on NSE/BSE with real-time updates. May 14, 2023 · After the upgrade, the five analysts covering Spectrum Pharmaceuticals are now predicting revenues of US$67m in 2023. 's business for stockholders, potential investors, and financial analysts. Feb 1, 2023 · The chart provided below shows analyst forward forecasts for Spectrum’s growing EBIT (earnings before interest and tax) over the next 5 years. fag trw xcm sjt qzp yme vvl mbc dad hvu drb wig bag qpu kpg